Mycobacterial Infections in the Elderly

Carlos Pérez-Guzmán; Mario H Vargas

doi:10.1055/s-0030-1265898

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2010; 31(5): 575-586
DOI: 10.1055/s-0030-1265898

Mycobacterial Infections in the Elderly

Carlos Pérez-Guzmán¹ ^, ² , Mario H. Vargas³ ^, ⁴

¹Coordinación de Investigación, Instituto de Salud del Estado de Aguascalientes, Aguascalientes, México
²Unidad de Medicina de Atención Ambulatoria, Instituto Mexicano del Seguro Social, Aguascalientes, Mexico
³Unidad de Investigación, Instituto Nacional de Enfermedades Respiratorias, México DF, México
⁴Unidad de Investigación Médica en Enfermedades Respiratorias, Instituto Mexicano del Seguro Social, México DF, México

Abstract

ABSTRACT

In 2008, elderly subjects accounted for more than 262,000 cases of smear-positive tuberculosis worldwide, reaching the highest age-adjusted rates in some regions. Elders are at a greater risk for reactivation of latent tuberculosis or acquisition of new infection, especially if they live in long-term care facilities or are smokers. Once overt clinical tuberculosis appears, they are at increased risk of hospitalization and death. Pulmonary tuberculosis presentation may be atypical in elderly people, as they tend to have lower prevalence of fever, sweating, or hemoptysis, and their chest x-rays show less cavities and more lower lung field involvement. Compared with younger patients, tuberculous elders seem to have lower frequency of positive PPD, but differences in sputum smear positivity are not clear. Regimen recommended for treating new cases of pulmonary tuberculosis is not different from other age groups: a two-month bactericidal phase with daily oral administration of isoniazid, rifampin, pyrazinamide, and ethambutol, and a continuation phase with isoniazid and rifampin daily during four months, though some variations are allowed. Directly observed strategy is highly recommended in the initial phase. Elders with pulmonary tuberculosis may require longer time to become smear negative and seem to have worse outcomes than younger patients.

KEYWORDS

Tuberculosis - aging - elderly

Full Text

References

REFERENCES

1 De Magalhaes J P. What is aging?. Available at http://www.senescence.info/definitions.html Accessed November 12, 2009
2 Orimo H, Ito H, Suzuki T, Araki A, Hosoi T, Sawabe M. Reviewing the definition of “elderly”. Geriatr Gerontol Int. 2006; 6 149-158
3 Orimo H. Reviewing the definition of elderly [in Japanese]. Nippon Ronen Igakkai Zasshi. 2006; 43 27-34
4 World Health Organization .Definition of an older or elderly person. Proposed working definition of an older person in Africa for the MDS Project. Available at http://www.who.int/healthinfo/survey/ageingdefnolder/en/index.html Accessed November 12, 2009
5 Katial R, Zheng W. Allergy and immunology of the aging lung. Clin Chest Med. 2007; 28 663-672
6 Bovornkitti S, Limlomwongse L. Environment and the ageing lung. Respirology. 1997; 2 169-172
7 World Health Organization .2009 Tuberculosis facts. http://Available at www.who.int/entity/tb/publications/2009/tbfactsheet_2009update_one_page.pdf Accessed February 10, 2010
8 World Health Organization .Global tuberculosis control: a short update to the 2009 report (supplemental online data). Available at http://www.who.int/tb/publications/global_report/2009/update/en Accessed February 20, 2010
9 World Health Organization .Global Tuberculosis Control: Epidemiology, Strategy, Financing. WHO Report 2009. Publication WHO/HTM/TB/2009. 411. Geneva, Switzerland; World Health Organization 2009
10 World Health Organization .World Health Statistics 2009. Available at http://www.who.int/whosis/en/index.html Accessed February 20, 2010
11 Ohmori M, Ishikawa N, Yoshiyama T, Uchimura K, Aoki M, Mori T. Current epidemiological trend of tuberculosis in Japan. Int J Tuberc Lung Dis. 2002; 6 415-423
12 Tuberculous infection and prevention [in Japanese]. Kekkaku. 2000; 75 619-623
13 Tam C M, Leung C C, Noertjojo K, Chan S L, Chan-Yeung M. Tuberculosis in Hong Kong: patient characteristics and treatment outcome. Hong Kong Med J. 2003; 9 83-90
14 García-Fernández C, Vera López I, Jaén Herreros F, Sanz-Gallardo M I, Palenque Mataix E, de Juanes Pardo J R. Tuberculosis en ancianos en un hospital general de la Comunidad de Madrid, 1994–2003. Med Interna. 2006; 23 161-165
15 Rajagopalan S, Yoshikawa T T. Tuberculosis in long-term-care facilities. Infect Control Hosp Epidemiol. 2000; 21 611-615
16 Zanni G R, Wick J Y. Treating tuberculosis in older adults. Consult Pharm. 2008; 23 844-846, 851–858
17 Shimouchi A, Koda S, Ochiai H. Survey on nosocomial infection of tuberculosis in nursing homes for elderly in Osaka City [in Japanese]. Kekkaku. 2007; 82 179-184
18 Gisselbrecht M. Tuberculosis in elderly persons living in institutions [in French]. Rev Mal Respir. 2004; 21 8S106-8S113
19 Bates M N, Khalakdina A, Pai M, Chang L, Lessa F, Smith K R. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med. 2007; 167 335-342
20 Dhamgaye T M. Tobacco smoking and pulmonary tuberculosis: a case-control study. J Indian Med Assoc. 2008; 106 216-219
21 Chiang C Y, Slama K, Enarson D A. Associations between tobacco and tuberculosis. Int J Tuberc Lung Dis. 2007; 11 258-262
22 Hassmiller K M. The association between smoking and tuberculosis. Salud Publica Mex. 2006; 48(Suppl 1) S201-S216
23 Wang J Y, Hsueh P R, Jan I S et al.. The effect of smoking on tuberculosis: different patterns and poorer outcomes. Int J Tuberc Lung Dis. 2007; 11 143-149
24 Leung C C, Li T, Lam T H et al.. Smoking and tuberculosis among the elderly in Hong Kong. Am J Respir Crit Care Med. 2004; 170 1027-1033
25 Sanya E O, Akande T M, Opadijo G, Olarinoye J K, Bojuwoye B J. Pattern and outcome of medical admission of elderly patients seen at University of Ilorin Teaching Hospital, Ilorin. Afr J Med Med Sci. 2008; 37 375-381
26 Low S, Ang L W, Cutter J et al.. Mortality among tuberculosis patients on treatment in Singapore. Int J Tuberc Lung Dis. 2009; 13 328-334
27 Lefebvre N, Falzon D. Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur Respir J. 2008; 31 1256-1260
28 Faustini A, Hall A J, Mantovani J, Sangalli M, Perucci C A. Regional group for the Survey of TB Treatment Outcomes . Treatment outcomes and relapses of pulmonary tuberculosis in Lazio, Italy, 1999-2001: a six-year follow-up study. Int J Infect Dis. 2008; 12 611-621
29 Lindoso A A, Waldman E A, Komatsu N K, Figueiredo S M, Taniguchi M, Rodrigues L C. Profile of tuberculosis patients progressing to death, city of São Paulo, Brazil, 2002. Rev Saude Publica. 2008; 42 805-812
30 Wang C S, Chen H C, Yang C J et al.. The impact of age on the demographic, clinical, radiographic characteristics and treatment outcomes of pulmonary tuberculosis patients in Taiwan. Infection. 2008; 36 335-340
31 Das S K, Mukherjee R S, Ghosh I N, Halder A K, Saha S K. A study of pulmonary tuberculosis in the elderly. J Indian Med Assoc. 2007; 105 432, 436, 438-439
32 Anyama N, Bracebridge S, Black C, Niggebrugge A, Griffin S J. What happens to people diagnosed with tuberculosis? A population-based cohort. Epidemiol Infect. 2007; 135 1069-1076
33 Borgdorff M W, Veen J, Kalisvaart N A, Nagelkerke N. Mortality among tuberculosis patients in the Netherlands in the period 1993-1995. Eur Respir J. 1998; 11 816-820
34 Pérez-Guzmán C, Vargas M H, Torres-Cruz A, Villarreal-Velarde H. Does aging modify pulmonary tuberculosis? A meta-analytical review. Chest. 1999; 116 961-967
35 Yamagishi F. Tuberculosis in the elderly [in Japanese]. Kekkaku. 2004; 79 481-486
36 Pérez-Guzman C, Torres-Cruz A, Villarreal-Velarde H, Vargas M H. Progressive age-related changes in pulmonary tuberculosis images and the effect of diabetes. Am J Respir Crit Care Med. 2000; 162 1738-1740
37 Cantalice Filho J P, Sant Anna C C, Bóia M N. Clinical aspects of pulmonary tuberculosis in elderly patients from a university hospital in Rio de Janeiro, Brazil [in Spanish]. J Bras Pneumol. 2007; 33 699-706
38 Rawat J, Sindhwani G, Juyal R. Clinico-radiological profile of new smear positive pulmonary tuberculosis cases among young adult and elderly people in a tertiary care hospital at Deheradun (Uttarakhand). Indian J Tuberc. 2008; 55 84-90
39 Ismail Y. Pulmonary tuberculosis—a review of clinical features and diagnosis in 232 cases. Med J Malaysia. 2004; 59 56-64
40 Villarreal-Velarde H, Vargas M H, Torres-Cruz A et al.. Tuberculosis pleuropulmonar en el anciano: estudio comparativo con otras edades. Rev Inst Nal Enf Respir (Mex). 1998; 11 111-116
41 Rocha M, Pereira S, Barros H, Seabra J. Does pulmonary tuberculosis change with ageing?. Int J Tuberc Lung Dis. 1997; 1 147-151
42 Craig S E, Bettinson H, Sabin C A, Gillespie S H, Lipman M C. Think TB! Is the diagnosis of pulmonary tuberculosis delayed by the use of antibiotics?. Int J Tuberc Lung Dis. 2009; 13 208-213
43 Kherad O, Herrmann F R, Zellweger J P, Rochat T, Janssens J P. Clinical presentation, demographics and outcome of tuberculosis (TB) in a low incidence area: a 4-year study in Geneva, Switzerland. BMC Infect Dis. 2009; 9 217
44 Cavalcanti ZdoR, de Albuquerque MdeF, Campello A R, Ximenes R, Montarroyos U, Verçosa M K. Characteristics of elderly tuberculosis patients in Recife, Brazil: a contribution to the tuberculosis control program. J Bras Pneumol. 2006; 32 535-543
45 Lee J H, Han D H, Song J W, Chung H S. Diagnostic and therapeutic problems of pulmonary tuberculosis in elderly patients. J Korean Med Sci. 2005; 20 784-789
46 Parimon T, Spitters C E, Muangman N, Euathrongchit J, Oren E, Narita M. Unexpected pulmonary involvement in extrapulmonary tuberculosis patients. Chest. 2008; 134 589-594
47 Fader T, Parks J, Khan N U, Manning R, Stokes S, Nasir N A. Extrapulmonary tuberculosis in Kabul, Afghanistan: a hospital-based retrospective review. Int J Infect Dis. 2010; 14 e102-e110
48 Kourbatova E V, Leonard Jr M K, Romero J, Kraft C, del Rio C, Blumberg H M. Risk factors for mortality among patients with extrapulmonary tuberculosis at an academic inner-city hospital in the US. Eur J Epidemiol. 2006; 21 715-721
49 Arciniegas W, Orjuela D L. Extrapulmonary tuberculosis: a review of 102 cases in Pereira, Colombia. Biomedica (Bogota). 2006; 26 71-80
50 te Beek L A, van der Werf M J, Richter C, Borgdorff M W. Increase in extrapulmonary tuberculosis in the Netherlands associated with an increase in the number of residents with non-Dutch nationality; observational study of data from 1993–2001 [iin Dutch]. Ned Tijdschr Geneeskd. 2008; 152 637-642
51 Sreeramareddy C T, Panduru K V, Verma S C, Joshi H S, Bates M N. Comparison of pulmonary and extrapulmonary tuberculosis in Nepal: a hospital-based retrospective study. BMC Infect Dis. 2008; 8 8
52 Teruel A B, Estornell L H, Rodríguez P C, Espejo A G. [Does age have any bearing on the incidence of extrapulmonary tuberculosis?]. Rev Esp Salud Publica. 2007; 81 57-58
53 Leung C C, Yew W W, Chan C K et al.. Tuberculosis in older people: a retrospective and comparative study from Hong Kong. J Am Geriatr Soc. 2002; 50 1219-1226
54 Kobashi Y, Mouri K, Fukuda M, Yoshida K, Miyashita N, Oka M. Transitional change in the clinical features of pulmonary tuberculosis. Respiration. 2008; 75 304-309
55 El-Khushman H, Momani J A, Sharara A M et al.. The pattern of active pulmonary tuberculosis in adults at King Hussein Medical Center, Jordan. Saudi Med J. 2006; 27 633-636
56 World Health Organization .Treatment of Tuberculosis: Guidelines. 4th ed. Publication WHO/HTM/TB/2009. 420 Geneva, Switzerland; World Health Organization 2009
57 Blumberg H M, Burman W J, Chaisson R E American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America et al. Treatment of tuberculosis. Am J Respir Crit Care Med. 2003; 167 603-662
58 Domínguez-Castellano A, Muniain M A, Rodriguez-Baño J et al.. Factors associated with time to sputum smear conversion in active pulmonary tuberculosis. Int J Tuberc Lung Dis. 2003; 7 432-438
59 Telzak E E, Fazal B A, Pollard C L, Turett G S, Justman J E, Blum S. Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clin Infect Dis. 1997; 25 666-670
60 Horne D J, Johnson C O, Oren E, Spitters C, Narita M. How soon should patients with smear-positive tuberculosis be released from inpatient isolation?. Infect Control Hosp Epidemiol. 2010; 31 78-84
61 Banu Rekha V V, Balasubramanian R, Swaminathan S et al.. Sputum conversion at the end of intensive phase of category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: an analysis of risk factors. Indian J Med Res. 2007; 126 452-458
62 Singla R, Osman M M, Khan N, Al-Sharif N, Al-Sayegh M O, Shaikh M A. Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. Int J Tuberc Lung Dis. 2003; 7 58-64
63 Ditah I C, Reacher M, Palmer C et al.. Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective. Thorax. 2008; 63 440-446
64 Didilescu C, Tigău M, Dediu I, Stoicescu I, Stoicescu I P. Clinical and epidemiological aspects of TB cases registered in persons aged >or = 65 between 2002–2006, at the TB dispensary of sector 4, Bucharest [in Romanian]. Pneumologia. 2008; 57 148-154
65 Farah M G, Tverdal A, Steen T W, Heldal E, Brantsaeter A B, Bjune G. Treatment outcome of new culture positive pulmonary tuberculosis in Norway. BMC Public Health. 2005; 5 14
66 Fuse E T, Takeda Y, Toyoda E, Mikami A, Kobayashi N, Kudo K. Predictive factors for treatment incompletion in elderly patients with newly diagnosed pulmonary tuberculosis [in Japanese]. Kekkaku. 2007; 82 803-808
67 American Thoracic Society, Centers for Disease Control and Prevention . Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med. 2000; 161(4 Pt 2) S221-S247
68 Mack U, Migliori G B, Sester M C. Lange et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J. 2009; 33 956-973
69 Huebner R E, Schein M F, Bass Jr J B. The tuberculin skin test. Clin Infect Dis. 1993; 17 968-975
70 Kobashi Y, Mouri K, Yagi S et al.. Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis. Chest. 2008; 133 1196-1202
71 Mori T, Sakatani M, Yamagishi F et al.. Specific detection of tuberculosis infection: an interferon-γ-based assay using new antigens. Am J Respir Crit Care Med. 2004; 170 59-64
72 Chee C BE, KhinMar K W, Gan S H, Barkham T M, Pushparani M, Wang Y T. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis–specific antigens. Am J Respir Crit Care Med. 2007; 175 282-287
73 Lalvani A, Pareek M. A 100 year update on diagnosis of tuberculosis infection. Br Med Bull. 2010; 93 69-84 , 10.1093/bmb/ldp039
74 Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007; 146 340-354
75 Ferrara G, Losi M, D'Amico R et al.. Interferon-gamma-release assays detect recent tuberculosis re-infection in elderly contacts. Int J Immunopathol Pharmacol. 2009; 22 669-677
76 Bennett D E, Courval J M, Onorato I et al.. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999–2000. Am J Respir Crit Care Med. 2008; 177 348-355
77 Runyon E H. American Thoracic Society . Preventive treatment in tuberculosis: a statement by the Committee on Therapy, American Thoracic Society. Am Rev Respir Dis. 1965; 91 297-298
78 Ferebee S H. Controlled chemoprophylaxis trials in tuberculosis: a general review. Bibl Tuberc. 1970; 26 28-106
79 Stead W W. Tuberculosis among elderly persons, as observed among nursing home residents. Int J Tuberc Lung Dis. 1998; 2(9, Suppl 1) S64-S70
80 Stead W W. Special problems in tuberculosis: tuberculosis in the elderly and in residents of nursing homes, correctional facilities, long-term care hospitals, mental hospitals, shelters for the homeless, and jails. Clin Chest Med. 1989; 10 397-405
81 Dooley S W, Villarino M E, Lawrence M et al.. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA. 1992; 267 2632-2634
82 Zaza S, Blumberg H M, Beck-Sagué C et al.. Nosocomial transmission of Mycobacterium tuberculosis: role of health care workers in outbreak propagation. J Infect Dis. 1995; 172 1542-1549
83 Hutton M D, Cauthen G M, Bloch A B. Results of a 29-state survey of tuberculosis in nursing homes and correctional facilities. Public Health Rep. 1993; 108 305-314
84 Centers for Disease Control and Prevention . Prevention and control of tuberculosis in facilities providing long-term care to the elderly: recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1990; 39(RR-10) 7-20
85 Ijaz K, Dillaha J A, Yang Z, Cave M D, Bates J H. Unrecognized tuberculosis in a nursing home causing death with spread of tuberculosis to the community. J Am Geriatr Soc. 2002; 50 1213-1218
86 Centers for Disease Control and Prevention . Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment—Advisory Council for the Elimination of Tuberculosis (ACET). MMWR Morb Mortal Wkly Rep. 1999; 48(RR-9) 1-13
87 Griffith D E, Aksamit T, Brown-Elliott B A ATS Mycobacterial Diseases Subcommittee et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175 367-416
88 Wayne L G, Sramek H A. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev. 1992; 5 1-25
89 Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990's. Clin Microbiol Rev. 2003; 16 319-354
90 Tortoli E. The new mycobacteria: an update. FEMS Immunol Med Microbiol. 2006; 48 159-178
91 Hoffner S E. Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria. Eur J Clin Microbiol Infect Dis. 1994; 13 937-941
92 Tanaka E, Kimoto T, Matsumoto H et al.. Familial pulmonary Mycobacterium avium complex disease. Am J Respir Crit Care Med. 2000; 161 1643-1647
93 Haverkort F. Australian Mycobacterium Reference Laboratory Network; Special Interest Group in Mycobacteria within the Australian Society for Microbiology . National atypical mycobacteria survey, 2000. Commun Dis Intell. 2003; 27 180-189
94 Marinho A, Fernandes G, Carvalho T, Pinheiro D, Gomes I. Nontuberculous mycobacteria in non-AIDS patients. Rev Port Pneumol. 2008; 14 323-337
95 Marras T K, Daley C L. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med. 2002; 23 553-567
96 Olivier K N, Weber D J, Wallace Jr R J Nontuberculous Mycobacteria in Cystic Fibrosis Study Group et al. Nontuberculous mycobacteria, I: Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med. 2003; 167 828-834
97 Olivier K N, Weber D J, Lee J H Nontuberculous Mycobacteria in Cystic Fibrosis Study Group et al. Nontuberculous mycobacteria, II: Nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med. 2003; 167 835-840
98 Witty L A, Tapson V F, Piantadosi C A. Isolation of mycobacteria in patients with pulmonary alveolar proteinosis. Medicine (Baltimore). 1994; 73 103-109
99 Horsburgh Jr C R. Epidemiology of Mycobacterium avium complex. In: Korvick JA, Benson CA Mycobacterium avium Complex Infection: Progress in Research and Treatment. New York; Marcel Dekker 1996: 1-22
100 Cassidy P M, Hedberg K, Saulson A, McNelly E, Winthrop K L. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis. 2009; 49 e124-e129
101 Al Jarad N, Demertzis P, Jones D J et al.. Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis. Thorax. 1996; 51 137-139
102 Suzuki J, Kataoka R, Sugimoto S, Morio S. An epidemiological study of registered cases positive for atypical mycobacteria in the tuberculosis surveillance system [in Japanese]. Nippon Koshu Eisei Zasshi. 2004; 51 40-47
103 Czajkowska M, Augustynowicz-Kopeć E, Zwolska Z et al.. Pulmonary mycobacterioses—frequency of occurrence, clinical spectrum and predisposing factors [in Polish]. Pneumonol Alergol Pol. 2002; 70 550-560
104 Schluger N W. Tuberculosis and nontuberculous mycobacterial infections in older adults. Clin Chest Med. 2007; 28 773-781
105 Sugihara E, Dambara T, Aiba M et al.. Clinical study on lung disease caused by non-tuberculous mycobacteriosis in the elderly [in Japanese]. Nippon Ronen Igakkai Zasshi. 2007; 44 503-506
106 Balkis M M, Kattar M M, Araj G F, Kanj S S. Fatal disseminated Mycobacterium simiae infection in a non-HIV patient. Int J Infect Dis. 2009; 13 e286-e287
107 Shimokawaji T, Kobayashi H, Kanoh S, Motoyoshi K. Disseminated Mycobacterium avium infection in an immunocompetent aged patient [in Japanese]. Nihon Kokyuki Gakkai Zasshi. 2006; 44 464-467
108 The Research Committee of the British Thoracic Society . Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment. Eur Respir J. 2003; 21 478-482
109 Iwata M, Ida M, Takeuchi E, Nakamura Y, Horiguchi T, Sato A. Middle lobe syndrome—incidence and relationship to atypical mycobacterial pulmonary disease [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi. 1996; 34 57-62

Mario H VargasM.D. M.S.

Unidad de Investigación, Instituto Nacional de Enfermedades Respiratorias

Tlalpan 4502, CP 14080, México DF, México

Email: mhvargasb@yahoo.com.mx